Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation: A single-center, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trial
書誌事項
- 公開日
- 2011-09
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- https://www.elsevier.com/legal/tdmrep-license
- DOI
-
- 10.1016/j.healun.2011.02.017
- 公開者
- Elsevier BV
この論文をさがす
収録刊行物
-
- The Journal of Heart and Lung Transplantation
-
The Journal of Heart and Lung Transplantation 30 (9), 990-996, 2011-09
Elsevier BV